Pharmac reconsidering decision to fund single brand of HRT patches

Wednesday 29 January 2025 · 3 outlets · 3 reports · updated Wed 29 Jan 2025, 5:57pm

In this story Pharmac, Mylan

Pharmac is reviewing its plan to fund only one brand of oestrogen patches after receiving considerable feedback. The patches are used for hormone replacement therapy and gender-affirming care. The agency previously announced it would move from the Estradot brand to a single funded brand in late 2024.

How they headlined it

4:23pm5:57pm

1. RNZWed 29 Jan 2025, 4:23pm

   Pharmac reconsiders decision on HRT oestrogen patches (opens in new tab)

2. StuffWed 29 Jan 2025, 4:33pm

   Pharmac u-turns on menopause patches following public outrage (opens in new tab)

3. 1News via RNZWed 29 Jan 2025, 5:57pm

   Pharmac walks back on HRT oestrogen patch decision, apologises (opens in new tab)